FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> buyouts | Millipore

Millipore confirms it's in play after shares rocket on rumors

Tools

Shares of Millipore shot up at the beginning of the week on a whiff of rumors that the company is in play. Late yesterday, the tool-maker made it official, announcing that it has hired Goldman Sachs to guide them through a look at strategic alternatives--including a possible sale.

Quoting sources, Reuters reports that Thermo Fisher Scientific has offered to buy the company for $6 billion. Millipore shares shot up 36 percent on Monday.

Millipore makes lab materials used in drug development. And aside from the official confirmation that a sale may be in the works, the company signaled it plans to stay mum unless it has a transaction to report.

"Millipore has not set a definitive timetable for completion of its evaluation and there can be no assurances that the process will result in any transaction," the company says in a release. "The company does not intend to disclose developments regarding this process unless and until the board of directors has approved a specific transaction."

- check out the Millipore press release
- here's the story from Reuters

Related Articles:
Millipore streamlines, closes plants
Millipore expands in Missouri


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Millipore   buyouts